#1663461 Iatrogenic Cushing’s Syndrome in the Setting of Decreased Oral Budesonide and Dexamethasone Mouth Rinse Catabolism due to Voriconazole-Mediated CYP3A4 Enzyme Inhibition

Few case reports have described the development of iatrogenic Cushing's in the setting of oral budesonide and dexamethasone mouth rinse formulations with concomitant voriconazole therapy. This abstract describes such a case which resolved with switching from voriconazole to isavuconazonium.